Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of Therapeutic Effects of ZAX.1400.EC.02 a Herbal Compound on Clinical Signs of Skin in Eczema Patients

NCT06758752 is registered in ClinicalTrials.gov with Fasa University of Medical Sciences as lead sponsor.

NCT NCT06758752
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06758752 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of Therapeutic Effects of ZAX.1400.EC.02 a Herbal Compound on Clinical Signs of Skin in Eczema Patients
Lead sponsor
Fasa University of Medical Sciences
Phase
Phase 2
Overall status
Active, not recruiting
Start date
October 1, 2023
Completion date
December 30, 2026
Enrollment
110 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

atopic dermatitis, eczema, inflammation